logo
  • Downloads
  • Client Login
20th Celebration
  • About Us
    • Why DesertSci?
    • Our History
    • Our Approach
    • Our Clients
    • Publications
    • Contact Us
  • Products
    • BMOS
    • FELIX
    • LIGEX
    • Machine Learning: Scoring Protein-Ligand Binding
    • Proasis4
    • ProFusion
    • Scorpion
    • Spinifex
    • ViewContacts
    • Viper
  • Software Modules
    • Atom-Based Binding Site Clustering
    • Antibody Structure Based Drug Discovery
    • Antibody Complementarity Determining Regions
    • Antibody-Antigen Interactions
    • Residue Flexibility
    • WaterRank
    • WaterView
  • Modelling Support
  • Pricing
  • Latest News
Home > Software Modules > Antibody Complementarity Determining Regions

  • Atom-Based Binding Site Clustering
  • Antibody Structure Based Drug Discovery
  • Antibody Complementarity Determining Regions
  • Antibody-Antigen Interactions
  • Residue Flexibility Tool
  • WaterView
  • WaterRank

Antibody Complementarity Determining Regions

We have developed new technology to enable the routine analysis of the 3D structural aspects of complementarity determining regions (CDRs) aimed at facilitating the discovery of new biological entities or synthetic antibodies.

The key binding domains of antibodies are the Complementarity Determining Regions (CDRs) with a research focus on protein sequence data.

Our CDR software has been incorporated into existing Proasis tools and seamlessly links with  1D CDR protein sequence data with 3D CDR protein structure data.

We have provided you with the ability to routinely search based on sequence motifs and then visualise hits in molecular graphics applications all based on overlays of 3D CDRs.

Features include:

  • a comprehensive classification of CDRs to enable antibody domains that bind to a wide variety of targets, to be compared and contrasted with 3D analysis tools
  • visualisation of 3D overlays of CDR motifs that will help suggest sequence modifications leading to improved structure properties in NBEs
  • exploration of protein-protein interfaces enabling the discovery of small molecule drug candidates that may disrupt the formation of protein-protein complexes
  • new tools for the discovery of new protein therapeutics

Please contact us for more information on our CDR technology or to organise a webex demonstration

icon

News & Events

01 Nov 2022

New AlphaFold2 releases into Proasis

21 Jul 2022

Human Kinome fully represented in Proasis

06 Jun 2022

Proasis 2022 released

12 Jan 2022

Structure Based Drug Design support for Covid-19

more articles
image

Looking for FREE Academic Software?

find out more
Logo
  • contact
  • desertsci

info@desertsci.com

Ph: +612 8860 6466

Fax: +612 9680 7520

© 2011-2023 Desert Scientific Software

  • Site Map
  • Privacy
  • Terms & Conditions
Domani Digital